Alerte De Sécurité sur Premier Buffer A and B Reagent

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par Trinity Biotech.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
    2017-02-28
  • Date de publication de l'événement
    2017-02-28
  • Pays de l'événement
  • Source de l'événement
    DH
  • URL de la source de l'événement
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Medical Device Safety Alert
  • Cause
    Medical device safety alert: trinity biotech premier buffer a and b reagent medical device manufacturer, trinity biotech, has issued a medical device safety alert concerning its premier buffer a reagent [product code (lot number): 01-03-0080 (6873, 6669)] and premier buffer b reagent [product code (lot number):: 01-03-0081 (6374), 01-03-0096 (6859, 6639, 6506), 42664 (6528, 6633 and 6526)]. the manufacturer has received reports of difficulty in recovering controls (qc verification), using the above reagent lots, following system activation or standby mode. upon review, the manufacturer has confirmed that the first two test results following system activation or standby mode, with these reagent lots, may result in a low bias, whether they are a control or patient sample. the manufacturer is asking users of the above listed reagent lots for testing to review the following scenarios: if two controls were run directly after activation or standby and met acceptable criteria, there is no action required. if initial controls failed but were re-run and met acceptable criteria, there is no action required. if only patient samples were run directly after activation or standby, then a review of the first two (2) patient sample results is required. affected users should also take the following actions- discontinue the use of the above reagent lots. destroy any remaining product. confirm end-users’ laboratory practice of the use of two controls (qc verification) immediately following system standby and system activations. according to the manufacturer, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 28 february 2017.

Device

  • Modèle / numéro de série
  • Description du dispositif
    Medical Device Safety Alert: Trinity Biotech Premier Buffer A and B Reagent
  • Manufacturer

Manufacturer